Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy
Jensen, S.L.; Holmes, R.
Journal of Drugs in Dermatology Jdd 2(5): 554-556
2003
ISSN/ISBN: 1545-9616 PMID: 14558405 Document Number: 9839
Rosacea fulminans is characterized by the sudden onset of large, coalescing nodules and draining sinuses on the face. A few reports have linked medications to this condition, but none have described the onset of rosacea fulminans with pegylated interferon or ribavirin therapy. We report a patient who presented with rosacea fulminans after initiation of therapy for Hepatitis C.
Document emailed within 1 workday
Related Documents
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130Husa, P.; Husova, L. 2001: Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons Bratislavske Lekarske Listy 102(5): 248-252
Ferenci, P. 2006: Pegylated interferon plus ribavirin for chronic hepatitis C: the role of combination therapy today, tomorrow and in the future Minerva Gastroenterologica e Dietologica 52(2): 157-174
Chu, C-Jen.; Wang, Y-Jen.; Hwang, S-Jang.; Lu, R-Hwa.; Chang, F-Young.; Chang, C-Yu.; Yang, Y-Chun.; Lee, S-Dong. 2007: Kinetics of hepatitis C virus RNA load during pegylated interferon plus ribavirin therapy in Treatment-naive Chinese patients Hepato-Gastroenterology 54(75): 866-870
Sood, A.; Midha, V.; Sood, N.; Bansal, M. 2006: Pegylated interferon alfa 2b and oral ribavirin in patients with HCV-related cirrhosis Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(6): 283-285
Urbánek, P.; Subhanová, I.; Janousová, E.; Dusek, L.; Marecek, Z.; Brůha, R.; Petrtýl, J.; Brodanová, M. 2009: Efficacy of combination treatment with pegylated interferon plus ribavirin in patients chronically infected with HCV Vnitrni Lekarstvi 55(5): 474-479
Juszczyk, J.; Baka-Cwierz, B.; Beniowski, M.; Berak, H.; Bolewska, B.; Boroń-Kaczmarska, A.; Cianciara, J.; Cieśla, A.; Dziambor, A.; Gasiorowski, J.; Gietka, A.; Gliwińska, E.; Gładysz, A.; Gonciarz, Z.; Halota, W.; Horban, A.; Inglot, Młgorzata.; Janas-Skulina, U.; Janczewska-Kazek, E.; Jaskowska, J.; Jurczyk, K.; Knysz, B.; Kryczka, Wław.; Kuydowicz, J.; Lakomy, E.A.; Logiewa-Bazger, B.; Lyczak, A.; Mach, T.; Mazur, Włodzimierz.; Michalska, Z.; Modrzewska, R.; Nazzal, K.; Pabjan, Pł.; Piekarska, A.; Piszko, Pł.; Sikorska, K.; Szamotulska, K.; Sliwińska, M 2005: Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report) Przeglad Epidemiologiczny 59(3): 651-660
Słuzewski, W.; Kowala-Piaskowska, A.; Wysocki, J.; Figlerowicz, M.; Gorczyca, A.; Halota, W.; Jóźwiak, H.; Mizerski, J.; Mozer-Lisewska, I.; Pawłowska, M.łg.; Rokitka, M.; Strawińska, E.; Szamotulska, K. 2012: Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study Acta Poloniae Pharmaceutica 69(2): 319-326
Abutidze, A.; Bolokadze, N.; Chkhartishvili, N.; Sharvadze, L.; Tsertsvadze, T. 2016: Incidence of Tuberculosis among Hiv/Hcv Co-Infected Patients Receiving Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Georgia Georgian Medical News 252: 10-15
Mira, J.é A.; López-Cortés, L.F.; Merino, D.; Arizcorreta-Yarza, A.; Rivero, A.; Collado, A.; Ríos-Villegas, M.ía.J.; González-Serrano, M.; Torres-Tortoso, M.; Macías, J.; Valera-Bestard, B.ár.; Fernández-Fuertes, E.; Girón-González, J.é A.; Lozano, F.; Pineda, J.A. 2007: Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients Antiviral Therapy 12(8): 1225-1235
Vashakidze, E.; Imnadze, T. 2017: Combined Antiviral Treatment of Hepatitis C Virus Infection with Pegylated Interferon (Peg-Ifn) Α-2a (Pegferon) and Ribavirin (Copegus) in Inmates Georgian Medical News 264: 86-90
Mozer-Lisewska, I.; Dworacki, G.; Kaczmarek, E.; Słuzewski, W.; Kowala-Piaskowska, A.; Figlerowicz, M.; Kaczmarek, M.; Zeromski, J. 2005: Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin Przeglad Epidemiologiczny 59(2): 483-489
Elefsiniotis, I.S.; Fotos, N.V.; Pantazis, K.D.; Papadeli, D.; Mavrogiannis, C. 2007: Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study Hepato-Gastroenterology 54(75): 2 PPreceding Table of Contents
Mukherjee, S.; Lyden, E. 2006: Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series Hepato-Gastroenterology 53(70): 561-565
Bolukbas, C.; Bolukbas, F.F.; Kebdir, T.; Canayaz, L.; Dalay, A.R.; Kilic, G.; Ovunc, O. 2005: Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature Acta Gastro-Enterologica Belgica 68(4): 432-434
Srivastava, S.; Bertagnolli, M.; Lewis, J.H. 2005: Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic Journal of the National Medical Association 97(12): 1703-1707
Sypniewski, D.; Bednarek, I.; Gałka, S.; Loch, T.; Machnik, G. 2008: Influence of interferon-alpha and ribavirin on the transcription of interferon-gamma and IFN-gamma receptor genes in Jurkat cells Acta Poloniae Pharmaceutica 65(3): 345-351
Pawłowska, M.łg.; Halota, W. 2006: Pegylated interferon alpha in the treatment of chronic hepatitis B in HBe negative patients Przeglad Epidemiologiczny 60(1): 105-108
Vogel, M.; Nattermann, J.; Baumgarten, A.; Klausen, G.; Bieniek, B.; Schewe, K.; Jessen, H.; Boesecke, C.; Rausch, M.; Lutz, T.; Fenske, S.; Schranzo, D.; Kümmerle, T.; Schuler, C.; Theisen, A.; Mayr, C.; Seidel, T.; Rockstroh, J.ür.K. 2006: Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals Antiviral Therapy 11(8): 1097-1101
Guarnieri, A.; Marazzi, F.; Giorgi, M.P.; Canepari, G.; Pino, C.; Moggia, E.; Manca, A.; Ghezzi, P.M. 2002: Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(1): 79-81